Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Xin Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5136079950. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Serplulimab combined with gemcitabine, nab-paclitaxel, and stereotactic body radiotherapy versus gemcitabine and nab-paclitaxel as first-line treatment for rec… Co-author DOI 10.3389/fimmu.2026.1817221↗
  2. Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanced pancreatic ductal adenocarcinoma: a s… Co-author DOI 10.1136/bmjopen-2021-050558↗
  3. The Effect of Age on Short- and Long-Term Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Laparoscopic Pancreaticoduodenectomy. Co-author DOI 10.1097/mpa.0000000000001620↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huanji Xu · 1 shared paper, 2026 · strength 0.43
  2. Dan Cao · 1 shared paper, 2026 · strength 0.43
  3. Wanrui Lv · 1 shared paper, 2022 · strength 0.20
  4. Qiancheng Hu · 1 shared paper, 2022 · strength 0.20
  5. Dan Cao · 1 shared paper, 2022 · strength 0.20
  6. Bing Peng · 1 shared paper, 2020 · strength 0.12
  7. Lingwei Meng · 1 shared paper, 2020 · strength 0.12
  8. He Cai · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.